For the purposes of this chapter the following definitions shall apply unless the context clearly indicates or requires a different meaning.
SYNTHETIC CANNABINOID. Any laboratory-created compound that functions similar to the active ingredient in marijuana, tetrahydrocannabinol (THC), including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog containing a cannabinoid receptor agonist, such as:
(1) JWH-007 (l-pentyl-2-methyl-3-(l naphthoy)indole);
(2) JWH-015 (2-Methyl-1-propyl-1H-dndol-3-y1)-1-naphthalenymethanone);
(3) JWH-018 (l-pentyl-3-(l-naphtoyl)indole);
(4) JWH-019 (l-hexyl-3-(naphthalen-l-oyl)indole);
(5) Jwh-073 (naphthalen-l-yl-(l-butylindol-3-yl)methanone);
(6) JWH-081 (4-methoxynaphthalen-1-y1-(1-pentylindol-3-y1)methanone);
(7) JWH-098 (4-methoxynaphthalen-1-yl-(l-pentyl-2-methylindol-3-yl)methanone);
(8) JWH-122 (l-Pentyl-3-(4-methyl-l-naphthoyl)indole);
(9) JWH-164 (7-methoxynaphthalen-1-yl-(l-pentylindol-3-y1)methanone;
(10) JWH-200 (1-(2-morpholin-4-ylethyl)indol-3-yl)-naphthalen-l-ylmethanone);
(11) JWH-203 (2-(2-chlorophenyl)-l-(l-pentylindol-3-yl)ethanone;
(12) JWH-210 (4-ethylnaphthalen-1-yl-(l-pentylindol-3-y1)methanone;
(13) JWH-250 (l-pentyl-3-(2-methoxyphenylacetyl)indole);
(14) JWH-251 (l-pentyl-3-(2-methylphenylacetyl)indole);
(15) JWH-398 (l-pentyl-3-(4-chloro-l-naphthoyl)indole);
(16) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-2-(2-methyloctan-2yl)-6a,7,10,10-2-tetrahydrobenzo [c] chromen-l-ol);
(17) HU-211 ((6aS,10aS-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2yl)-6a,7,10,10a-l-tetrahydrobenzo [c] chromen-1-ol);
(18) HU-308 ([(lR,2R,5R)-2[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]methanol);
(19) HU-331 ((3-hydroxy-2- [(lR,6R)-3-methyl-6-(l-methylethenyl)-2-cyclohexen-l-yl]-5-pentyl-2,5-cyclohexadiene-l,4-dione);
(20) CP 55,940 (2-[lR,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-5-(2-methyl-octan-2-yl)phenol);
(21) CP 47,497 (2-[(R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2yl)phenol) and its homologues;
(22) WIN 55,212-2 (R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3 -de)-1,4-benzoxazin-6-y1]-1-nepthalenylmethanone);
(23) RCS-4 ((4-methoxyphenyl)(l-pentyl-lH-indol-3-yl)methanone);
(24) RCS-8 (l-(l-(2-cyclohexylethyl)-lH-indol-3-yl)-2-(2-methoxyphenyl1)ethanone).
SYNTHETIC STIMULANT. Any compound which is a federally controlled Schedule I substance such as cathinone, methcathinone, MDMA and MDEA, including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance which have a stimulant effect on the central nervous system. Upon banning, any of the following substance or substances which contain the described characteristics shall be considered a SYNTHETIC STIMULANT:
(1) 3-Fluoromethcathinone;
(2) 4-Fluoromethcathinone (other name: Flephedrone);
(3) 3,4-Methylenedioxymethcathinone (other name: methylone, MDMC);
(4) 3,4-Methylenedioxypryrovalerone (other name: MDPV);
(5) 4-Methylmethcathinon (other names: mephedrone, 4-MMC);
(6) 4-Methoxymethcathinone (other names: methedrone, bk-PMMA,PMMC);
(7) 4-Ethylmethcathinone (other name: 4-EMC);
(8) Ethcathinone;
(9) Beta-keto-N-methylbenzodioxyolylpropylamine (other names: butylone, bk-MBDB);
(10) Napthylpyrovalerone (other names: naphyrone, NRG-1);
(11) N,N-dimethylcathinone (other name: metamfepramone);
(12) Alpha-pyrrolidinopropiophenone (other name: alpha-PPP);
(13) 4-methoxy-alpha-pyrrolidinopropiophenone (other name: MOPPP);
(14) 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone (other name: MDPPP);
(15) Alpha-pyrrolidinovalerophenone (other name: alpha-PVP);
(16) 6,7-kihydro-5H-indeno(5,6-d)-l,3-dioxal-6-amine) (other name: MDAI);
(17) Any compound that is structurally derived from 2-amino-l-phenyl-1-propanone by modification or substitution in any of the following ways:
(a) In the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
(b) At the 3-position with an alkyl substituent;
(c) At the nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups;
(d) Or by inclusion of the nitrogen atom in a cyclic structure.
(Ord. 764, passed 6-25-12)